Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report
We report improved lung function and quality of life following daily use of guaifenesin/dextromethorphan (Mucinex DM®, Reckitt Benckiser) for the treatment of mucus-related symptoms in a patient with COPD, who presented with increasing dyspnea, progressive cough and chest congestion.
Main Authors: | William W. Storms, Judi E. Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007118300947 |
Similar Items
-
Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report
by: Ethan Singer, et al.
Published: (2019-01-01) -
Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report
by: William W. Storms, et al.
Published: (2018-01-01) -
The quality of life of farmers with chronic obstructive pulmonary disease (COPD)
by: Joanna Milanowska, et al.
Published: (2017-06-01) -
Case report: Pulmonary amyloidosis in two patients with chronic obstructive lung disease (COPD)
by: Haya Mardahayev, et al.
Published: (2019-01-01) -
The Study Of Processes Of Guaifenesin
by: Yu-Chu Hsu, et al.
Published: (1994)